[144] Takeda Pharmaceutical Company Limited American SEC Filing

Rhea-AI Filing Summary

The Form 144 filing indicates that an unidentified holder intends to sell 28,552 American Depositary Shares (ADSs) of Takeda Pharmaceutical Company Ltd. (NYSE: TAK) through Interactive Brokers on or about 9 July 2025. The planned sale represents an aggregate market value of US$440,271.84, implying an approximate price of US$15.42 per ADS. The shares derive from restricted stock unit (RSU) awards that vested on 1 July 2025. No other securities have been sold by the filer in the past three months, and the total shares outstanding for Takeda are disclosed as 123,490,548 ADSs, making the proposed sale equal to roughly 0.02 % of the class. No adverse information about Takeda’s operations is asserted, and the filer affirms compliance with Rule 144 and Rule 10b5-1 representations.

Insights

Securities Analyst

TL;DR: Small insider sale (28.5k ADS) worth ~US$440k; immaterial versus Takeda’s float—neutral signal.

The filing is a routine Form 144 notification. The proposed disposition amounts to ~0.02 % of Takeda’s outstanding ADSs and is valued at less than half a million dollars, negligible against the company’s multi-billion-dollar market capitalization. Because the shares stem from recently vested RSUs, the transaction likely serves liquidity or tax-planning purposes rather than signaling a view on fundamentals. No pattern of recent sales is noted, and the filer certifies absence of undisclosed negative information. Overall, I view the filing as not impactful for valuation or sentiment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	28552	440271.84	123490548	07/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/01/2025	Restricted Stock Unit Awards - Vested.	Takeda Pharmaceutical Company Limited			103360	07/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Takeda (TAK) ADSs are being sold under this Form 144 notice?

The filer plans to sell 28,552 ADSs.

What is the aggregate market value of the proposed Takeda ADS sale?

The sale is valued at approximately US$440,271.84.

When is the approximate sale date listed in the Form 144 for Takeda?

The shares are expected to be sold on or about 9 July 2025.

What percentage of Takeda’s outstanding ADSs does the proposed sale represent?

Roughly 0.02 % of the 123,490,548 ADSs outstanding.

Where will the Takeda ADSs be sold according to the filing?

Through Interactive Brokers LLC on the NYSE.